Abstract
ObjectiveOff-label drug use seems to be integral to adult palliative care pharmacotherapy. Balancing potential risks and benefits in the context of limited therapeutic options is challenging. To provide specific support...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have